483 related articles for article (PubMed ID: 35008876)
21. Chorioallantoic membrane vascularization. A meta-analysis.
Ribatti D; Tamma R; Annese T
Exp Cell Res; 2021 Aug; 405(2):112716. PubMed ID: 34186097
[TBL] [Abstract][Full Text] [Related]
22. The chorioallantoic membrane: A novel approach to extrapolate data from a well-established method.
Maugeri A; Lombardo GE; Navarra M; Cirmi S; Rapisarda A
J Appl Toxicol; 2022 Jun; 42(6):995-1003. PubMed ID: 34874573
[TBL] [Abstract][Full Text] [Related]
23. The In Ovo Chick Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma.
Li M; Pathak RR; Lopez-Rivera E; Friedman SL; Aguirre-Ghiso JA; Sikora AG
J Vis Exp; 2015 Oct; (104):. PubMed ID: 26484588
[TBL] [Abstract][Full Text] [Related]
24. Chapter 2. Chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inflammatory and tumor cells or purified effector molecules.
Deryugina EI; Quigley JP
Methods Enzymol; 2008; 444():21-41. PubMed ID: 19007659
[TBL] [Abstract][Full Text] [Related]
25. Angiogenesis and diabetes: different responses to pro-angiogenic factors in the chorioallantoic membrane assay.
Di Marco GS; Alam A; Dol F; Corvol P; Gasc JM; Larger E
Mol Med; 2008; 14(11-12):705-14. PubMed ID: 18670619
[TBL] [Abstract][Full Text] [Related]
26. A comparative study on the effects of tumor necrosis factor-alpha (TNF-alpha), human angiogenic factor (h-AF) and basic fibroblast growth factor (bFGF) on the chorioallantoic membrane of the chick embryo.
Olivo M; Bhardwaj R; Schulze-Osthoff K; Sorg C; Jacob HJ; Flamme I
Anat Rec; 1992 Sep; 234(1):105-15. PubMed ID: 1384395
[TBL] [Abstract][Full Text] [Related]
27. Laser speckle contrast analysis (LASCA) technology for the semiquantitative measurement of angiogenesis in in-ovo-tumor-model.
Pion E; Asam C; Feder AL; Felthaus O; Heidekrueger PI; Prantl L; Haerteis S; Aung T
Microvasc Res; 2021 Jan; 133():104072. PubMed ID: 32949573
[TBL] [Abstract][Full Text] [Related]
28. Methods for Analyzing Tumor Angiogenesis in the Chick Chorioallantoic Membrane Model.
Ames JJ; Henderson T; Liaw L; Brooks PC
Methods Mol Biol; 2016; 1406():255-69. PubMed ID: 26820962
[TBL] [Abstract][Full Text] [Related]
29. Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies.
Chu PY; Koh AP; Antony J; Huang RY
Cells Tissues Organs; 2022; 211(2):222-237. PubMed ID: 33780951
[TBL] [Abstract][Full Text] [Related]
30. Utilisation of Chick Embryo Chorioallantoic Membrane as a Model Platform for Imaging-Navigated Biomedical Research.
Chen L; Wang S; Feng Y; Zhang J; Du Y; Zhang J; Ongeval CV; Ni Y; Li Y
Cells; 2021 Feb; 10(2):. PubMed ID: 33671534
[TBL] [Abstract][Full Text] [Related]
31. The chick embryo chorioallantoic membrane as an in vivo experimental model to study human neuroblastoma.
Ribatti D; Tamma R
J Cell Physiol; 2018 Jan; 234(1):152-157. PubMed ID: 30078179
[TBL] [Abstract][Full Text] [Related]
32. A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assay.
Chen H; Wang CS; Li M; Sanchez E; Li J; Berenson A; Wirtschafter E; Wang J; Shen J; Li Z; Bonavida B; Berenson JR
Int J Oncol; 2010 Jul; 37(1):71-9. PubMed ID: 20514398
[TBL] [Abstract][Full Text] [Related]
33. Vascular disrupting activity of combretastatin analogues.
Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
[TBL] [Abstract][Full Text] [Related]
34. Cell Biological Assays for Measuring Angiogenic Activities of CCN Proteins.
Shimo T; Takigawa M
Methods Mol Biol; 2017; 1489():239-249. PubMed ID: 27734381
[TBL] [Abstract][Full Text] [Related]
35. Chicken chorioallantoic membrane angiogenesis model.
Ribatti D
Methods Mol Biol; 2012; 843():47-57. PubMed ID: 22222520
[TBL] [Abstract][Full Text] [Related]
36. The chick embryo chorioallantoic membrane as an in vivo experimental model to study multiple myeloma.
Ribatti D; Tamma R
Enzymes; 2019; 46():23-35. PubMed ID: 31727275
[TBL] [Abstract][Full Text] [Related]
37. Angiogenic response induced by acellular femoral matrix in vivo.
Conconi MT; Nico B; Rebuffat P; Crivellato E; Parnigotto PP; Nussdorfer GG; Ribatti D
J Anat; 2005 Jul; 207(1):79-83. PubMed ID: 16011546
[TBL] [Abstract][Full Text] [Related]
38. Assessment of angiogenic properties of biomaterials using the chicken embryo chorioallantoic membrane assay.
Azzarello J; Ihnat MA; Kropp BP; Warnke LA; Lin HK
Biomed Mater; 2007 Jun; 2(2):55-61. PubMed ID: 18458436
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of angiogenic activities of hyaluronan oligosaccharides of defined minimum size.
Cui X; Xu H; Zhou S; Zhao T; Liu A; Guo X; Tang W; Wang F
Life Sci; 2009 Oct; 85(15-16):573-7. PubMed ID: 19720068
[TBL] [Abstract][Full Text] [Related]
40. Chorioallantoic Membrane Microtumor Model to Study the Mechanisms of Tumor Angiogenesis, Vascular Permeability, and Tumor Cell Intravasation.
Deryugina EI
Methods Mol Biol; 2016; 1430():283-98. PubMed ID: 27172961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
